The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of cavitation-enhanced drug delivery (CEeDD) by sonosensitive particles and focused ultrasound applied to colorectal metastases in the liver.
 
Jeffrey Rubasingham
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Calum Crake
Employment - OxSonics Therapeutics
Stock and Other Ownership Interests - OxSonics Therapeutics
Patents, Royalties, Other Intellectual Property - OxSonics Therapeutics
 
Christian Coviello
Employment - GE Healthcare
Stock and Other Ownership Interests - OxSonics Therapeutics
Patents, Royalties, Other Intellectual Property - OxSonics Therapeutics
 
Cliff Rowe
Employment - OxSonics Therapeutics
Leadership - OxSonics Therapeutics
 
Paul Boulos
No Relationships to Disclose
 
Jessica Thorne
No Relationships to Disclose
 
Madhurima Chetan
No Relationships to Disclose
 
Paul Lyon
Leadership - Lyon Medical Ltd
Stock and Other Ownership Interests - Lyon Medical Ltd; OxSonics Therapeutics
Consulting or Advisory Role - OxSonics Therapeutics
 
Alexander Thomas
No Relationships to Disclose
 
Daniel McAleese
No Relationships to Disclose
 
Srikanth Reddy
No Relationships to Disclose
 
Laura Spiers
No Relationships to Disclose
 
Sam Dobbie
No Relationships to Disclose
 
Fergus Gleeson
Employment - Alliance Medical; Optellum
Stock and Other Ownership Interests - Optellum
Consulting or Advisory Role - Alliance Medical
Research Funding - GE Healthcare; Optellum; Roche
 
Michael Gray
Patents, Royalties, Other Intellectual Property - Nanoparticles patents pending
 
Robert Carlisle
Stock and Other Ownership Interests - OxSonics Therapeutics
 
Constantin Coussios
Leadership - ConvaTec; OrganOx; Orthoson; OxSonics Therapeutics
Stock and Other Ownership Interests - ConvaTec; OrganOx; Orthoson; OxSonics Therapeutics
Consulting or Advisory Role - OrganOx; Orthoson
Patents, Royalties, Other Intellectual Property - OrganOx; Orthoson; OxSonics Therapeutics
Travel, Accommodations, Expenses - ConvaTec; Orthoson
(OPTIONAL) Uncompensated Relationships - OxSonics Therapeutics unpaid director
 
Rachel Kerr
No Relationships to Disclose